Asia Pacific Bioanalytical Testing Services Market Forecast to 2030

Asia Pacific Bioanalytical Testing Services Market Forecast to 2030

Asia Pacific Bioanalytical Testing Services Market Forecast to 2030 – Regional Analysis – by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological Disorders, Metabolic Disorders, Autoimmune Disorders, Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others]

Send Enquiry
Item ID: BMIRE00029556 Category: Tag:

$2,485 – $3,885

Description

The Asia Pacific bioanalytical testing services market was valued at US$ 1,004.33 million in 2022 and is expected to reach US$ 2,252.88 million by 2030; it is estimated to grow at a CAGR of 10.6% from 2022 to 2030.

Uninterrupted Growth of Pharmaceuticals Industry Companies Fuel the Asia Pacific Bioanalytical Testing Services Market

The research & development, production, and distribution of medicinal drugs and other pharmaceutical products are the major areas of the pharmaceutical industry. Global pharmaceutical consumption is rising with the increasing need for drugs to treat age-related diseases and chronic diseases. According to the WHO, the elderly population aged 60 or above is projected to double from 2020 to 2050, reaching ~2.1 billion by 2050. A rise in the geriatric population would contribute to a surge in incidences of chronic diseases, such as cardiovascular diseases, cancer, hypertension, osteoarthritis, and diabetes mellitus. Thus, chronic diseases have been a major area of focus for pharmaceutical companies.

New drug development is a resource-, cost-, and time-intensive process, where later clinical stages result in significant costs. Several pharmaceutical companies are opting for bioanalytical testing services for drug development and validation of assays in both clinical and preclinical stages. Generics and branded drug compounds are mostly small molecules. Generics manufacturers conduct and submit bioanalytical testing results to overcome the issue of patent expiration. Thus, with the uninterrupted proliferation of the pharmaceutical industry, bioanalytical testing service providers are likely to experience a continuous rise in demand for their services in the future, which would lead to new growth opportunity in the bioanalytical testing services market.

Asia Pacific Bioanalytical Testing Services Market Overview

The Asia Pacific bioanalytical testing services market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The Asia Pacific bioanalytical testing services market is expected to witness the highest growth during the study period due to the increasing demand for outsourcing services in the low-cost labor markets. Delivery centers in Indonesia, India, and China typically support outsourcing services in this region. China is gaining popularity as a delivery location for both onshore and offshore customers based in Japan. Additionally, governments across the region place increasing importance on preventing the spread of infectious diseases, contributing significantly to the expansion of the bioanalytical testing services market. For instance, Ministries of Health, local universities, and Non-Governmental Organizations (NGOs) to ensure continued support and sustainability of this capacity-building initiative. The implementation research training was part of a broader program of collaborative research projects based on surveillance and response in the Indo-Pacific region – the “Partners in Tropical Health” project.

Asia Pacific Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Bioanalytical Testing Services Market Segmentation

The Asia Pacific bioanalytical testing services market is segmented based on test type, disease indication, end user, and country.

Based on test type, the Asia Pacific bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022.

Based on disease indication, the Asia Pacific bioanalytical testing services market is segmented into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held the largest market share in 2022.

Based on end user, the Asia Pacific bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2022.

Based on country, the Asia Pacific bioanalytical testing services market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific bioanalytical testing services market share in 2022.

SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, ICON Plc, and Intertek Group Plc are some of the leading companies operating in the Asia Pacific bioanalytical testing services market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

, ,

Year of Publication:

At 10.6% CAGR, the Asia Pacific Bioanalytical Testing Services Market is Speculated to be worth US$ 2,252.88 million by 2030, says The Research Team

According to The Research Team’ research, the Asia Pacific bioanalytical testing services market was valued at US$ 1,004.33 million in 2022 and is expected to reach US$ 2,252.88 million by 2030, registering a CAGR of 10.6% from 2022 to 2030. Increasing outsourcing of R&D activities by pharmaceutical companies and high demand for analytical testing of biosimilars and biologics are among the critical factors attributed to the Asia Pacific bioanalytical testing services market expansion.

Biologics are among the most promising therapeutic areas important in the pharmaceutical market. The rising number of cases of chronic diseases such as inflammatory bowel diseases, cancer, and rheumatoid arthritis propels the demand for biologics. However, the high cost of biologics has redirected the focus of drug developers and healthcare stakeholders toward biosimilars in recent years. Additionally, the imminent expiry of the patents and exclusivity periods of biologics have also created opportunities for the development of biosimilars. According to McKinsey & Co., ~19 high-volume biologics would lose exclusivity by 2025. Additionally, 39 more high-volume biologics are expected to lose patent protection between 2026 and 2032, with more biologics likely to follow. The anticipated rise in biosimilar R&D would boost the demand for related bioanalytical testing services-compatibility studies for biosimilars, stability testing, product release testing, and biosimilar protein analysis-to reduce the risks involved with medication development. Thus, the rise in demand for analytical testing of biosimilars is boosting the growth of the bioanalytical testing services market.

On the contrary, high cost associated to bioanalytical testing services hurdles the growth of Asia Pacific bioanalytical testing services market.

Based on test type, the Asia Pacific bioanalytical testing services market is categorized into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held 23.4% market share in 2022, amassing US$ 235.16 million. It is projected to garner US$ 570.35 million by 2030 to expand at 11.7% CAGR during 2022-2030.

Based on disease indication, the Asia Pacific bioanalytical testing services market is categorized into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held 23.2% market share in 2022, amassing US$ 233.22 million. It is projected to garner US$ 559.29 million by 2030 to expand at 11.6% CAGR during 2022-2030.

Based on end user, the Asia Pacific bioanalytical testing services market is categorized into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held 61.0% share of Asia Pacific bioanalytical testing services market in 2022, amassing US$ 612.26 million. It is projected to garner US$ 1,429.12 million by 2030 to expand at 11.2% CAGR during 2022-2030.

Based on country, the Asia Pacific bioanalytical testing services market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 27.4% share of Asia Pacific bioanalytical testing services market in 2022. It was assessed at US$ 274.97 million in 2022 and is likely to hit US$ 636.92 million by 2030, exhibiting a CAGR of 11.1% during 2022-2030.

Key players operating in the Asia Pacific bioanalytical testing services market are SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, and Biomarker Services LLC, ICON Plc, and Intertek Group Plc, among others.

In July 2021, ICON plc completed the acquisition of PRA Health Sciences. In May 2021, Labcorp expands bioanalytical services in Asia-Pacific region with integrated laboratory in Singapore.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioanalytical testing services market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioanalytical testing services market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific bioanalytical testing services market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Bioanalytical Testing Services Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
5. Asia Pacific Bioanalytical Testing Services Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
5.2 Key Market Restraints:
5.2.1 High Cost Associated to Bioanalytical Testing Services
5.3 Key Market Opportunities
5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
5.4 Future Trends
5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
5.5 Impact Analysis:
6. Bioanalytical Testing Services Market – Asia Pacific Market Analysis
6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 – 2030
7. Asia Pacific Bioanalytical Testing Services Market – Revenue and Forecast to 2030 – by Services
7.1 Overview
7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
7.3 Pharmacokinetics
7.3.1 Overview
7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Biomarkers
7.4.1 Overview
7.4.2 Biomarkers: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Immunogenicity
7.5.1 Overview
7.5.2 Immunogenicity: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Virology Testing
7.6.1 Overview
7.6.2 Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.6.2.1 In-Vitro Virology Testing
7.6.2.1.1 Overview
7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.6.3 In-Vivo Virology Testing
7.6.3.1 Overview
7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Cell-Based Assays
7.7.1 Overview
7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Bioanalytical Testing Services Market – Revenue and Forecast to 2030 – by Disease Indication
8.1 Overview
8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
8.3 Cardiovascular
8.3.1 Overview
8.3.2 Cardiovascular: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Neurological Diseases
8.4.1 Overview
8.4.2 Neurological Diseases: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Autoimmune Disorders
8.5.1 Overview
8.5.2 Autoimmune Disorders: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Respiratory Diseases
8.6.1 Overview
8.6.2 Respiratory Diseases: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Metabolic Disorders
8.7.1 Overview
8.7.2 Metabolic Disorders: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Oncology
8.8.1 Overview
8.8.2 Oncology: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Sexual Health
8.9.1 Overview
8.9.2 Sexual Health: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.10 Bone Disease
8.10.1 Overview
8.10.2 Bone Disease: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.11 Others
8.11.1 Overview
8.11.2 Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Bioanalytical Testing Services Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Pharmaceutical and Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organization (CRO)
9.4.1 Overview
9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Development And Manufacturing Organization (CDMO)
9.5.1 Overview
9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Bioanalytical Testing Services Market – Country Analysis
10.1 Asia Pacific Bioanalytical Testing Services Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.1.1 Asia Pacific Bioanalytical Testing Services Market by Country
10.1.1.2 China
10.1.1.2.1 Overview
10.1.1.2.2 China Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 China Bioanalytical Testing Services Market, by Services
10.1.1.2.3.1 China Bioanalytical Testing Services Market, by Virology Testing
10.1.1.2.4 China Bioanalytical Testing Services Market, by Disease Indication
10.1.1.2.5 China Bioanalytical Testing Services Market, by End User
10.1.1.3 Japan
10.1.1.3.1 Overview
10.1.1.3.2 Japan Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Japan Bioanalytical Testing Services Market, by Services
10.1.1.3.3.1 Japan Bioanalytical Testing Services Market, by Virology Testing
10.1.1.3.4 Japan Bioanalytical Testing Services Market, by Disease Indication
10.1.1.3.5 Japan Bioanalytical Testing Services Market, by End User
10.1.1.4 India
10.1.1.4.1 Overview
10.1.1.4.2 India Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 India Bioanalytical Testing Services Market, by Services
10.1.1.4.3.1 India Bioanalytical Testing Services Market, by Virology Testing
10.1.1.4.4 India Bioanalytical Testing Services Market, by Disease Indication
10.1.1.4.5 India Bioanalytical Testing Services Market, by End User
10.1.1.5 Australia
10.1.1.5.1 Overview
10.1.1.5.2 Australia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.3 Australia Bioanalytical Testing Services Market, by Services
10.1.1.5.3.1 Australia Bioanalytical Testing Services Market, by Virology Testing
10.1.1.5.4 Australia Bioanalytical Testing Services Market, by Disease Indication
10.1.1.5.5 Australia Bioanalytical Testing Services Market, by End User
10.1.1.6 South Korea
10.1.1.6.1 Overview
10.1.1.6.2 South Korea Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.3 South Korea Bioanalytical Testing Services Market, by Services
10.1.1.6.3.1 South Korea Bioanalytical Testing Services Market, by Virology Testing
10.1.1.6.4 South Korea Bioanalytical Testing Services Market, by Disease Indication
10.1.1.6.5 South Korea Bioanalytical Testing Services Market, by End User
10.1.1.7 Rest of Asia Pacific
10.1.1.7.1 Overview
10.1.1.7.2 Rest of Asia Pacific Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.7.3 Rest of Asia Pacific Bioanalytical Testing Services Market, by Services
10.1.1.7.3.1 Rest of Asia Pacific Bioanalytical Testing Services Market, by Virology Testing
10.1.1.7.4 Rest of Asia Pacific Bioanalytical Testing Services Market, by Disease Indication
10.1.1.7.5 Rest of Asia Pacific Bioanalytical Testing Services Market, by End User
11. Bioanalytical Testing Services Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioanalytical Testing Services Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 SGS SA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Pharmaron Beijing Co Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Element Materials Technology Group Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Eurofins Scientific SE
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Labcorp Drug Development Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Syneos Health Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 ICON Plc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Intertek Group Plc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific Bioanalytical Testing Services Market Segmentation
Table 2. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 3. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Virology Testing
Table 4. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Disease Indication
Table 5. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 6. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 7. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Virology Testing
Table 8. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Disease Indication
Table 9. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 10. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 11. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Virology Testing
Table 12. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Disease Indication
Table 13. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 14. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 15. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Virology Testing
Table 16. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Disease Indication
Table 17. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 18. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 19. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Virology Testing
Table 20. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Disease Indication
Table 21. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 22. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 23. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Virology Testing
Table 24. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Disease Indication
Table 25. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 26. Recent Inorganic Growth Strategies in the Bioanalytical Testing Services Market
Table 27. Recent Organic Growth Strategies in the Bioanalytical Testing Services Market
Table 28. Glossary of Terms, Asia Pacific Bioanalytical Testing Services Market

LIST OF FIGURES

Figure 1. Asia Pacific Bioanalytical Testing Services Market Segmentation, By Country
Figure 2. Asia Pacific – PEST Analysis
Figure 3. Asia Pacific Bioanalytical Testing Services Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Asia Pacific Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Asia Pacific Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
Figure 7. Pharmacokinetics: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Biomarkers: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Immunogenicity: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. In-Vitro Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. In-Vivo Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cell-Based Assays: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 16. Cardiovascular: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Neurological Diseases: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Autoimmune Disorders: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Respiratory Diseases: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Metabolic Disorders: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Oncology: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Sexual Health: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Bone Disease: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Asia Pacific Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
Figure 26. Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Contract Research Organization (CRO): Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Asia Pacific Bioanalytical Testing Services Market, by Country, 2022 ($ Million)
Figure 31. Asia Pacific Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
Figure 32. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 33. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 34. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 36. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 38. Growth Strategies in the Bioanalytical Testing Services Market

The List of Companies – Asia Pacific Bioanalytical Testing Services Market

1. SGS SA
2. Pharmaron Beijing Co Ltd
3. Element Materials Technology Group Ltd
4. Charles River Laboratories International Inc
5. Eurofins Scientific SE
6. Labcorp Drug Development Inc
7. Syneos Health Inc
8. ICON Plc
9. Intertek Group Plc

Reviews

There are no reviews yet.

Be the first to review “Asia Pacific Bioanalytical Testing Services Market Forecast to 2030”